Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
cefpodoxime (cefpodoxime proxetil)
Alkaloid AD Skopje
J01DD13
cefpodoxime (cefpodoxime proxetil)
40mg/5ml
powder for oral suspension
64.8g powder in 100ml plastic vial with, measuring cup and dosing syringe
Prescription
Registered
2022-11-03
1 Rexocef 40 mg/5 ml powder for oral suspension Summary of Product Characteristics SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Rexocef ® 40 mg/5 ml powder for oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 5 ml oral suspension contains 40 mg cefpodoxime as cefpodoxime proxetil 1 ml oral suspension contains 8 mg cefpodoxime as cefpodoxime proxetil Excipients: Sucrose 2465 mg/ 5 ml Aspartame (E951) 20 mg/ 5 ml Sodium benzoate (E211) 10 mg/ 5 ml For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM * Powder for oral suspension. Almost white to pale yellow coloured powder. After it is mixed with water it turns into off-white to pale yellow suspension with a characteristic banana odour. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Rexocef powder for oral suspension is indicated for the treatment of the following infections when caused by bacteria susceptible to cefpodoxime (see section 5.1) in children at the age of 4 weeks to 12 years who need oral therapy. _ _ Ear, nose and throat infections: - tonsillitis, pharyngitis; - sinusitis; - acute otitis media. Lower respiratory tract infections: - pneumonia and bronchopneumonia; - acute exacerbation of chronic bronchitis (AECB). Non-complicated urinary tract infections. Skin and soft tissue infections. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 2 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _ _ _Posology _ ADULTS AND ELDERLY Not applicable for this product. PAEDIATRIC POPULATION The dose for children at the age of 4 weeks to 12 years of age is 5 to 12 mg/kg body weight a day to be taken as 2 separate doses on every 12 hours. The usual dose is 2 x 4 mg/kg body weight a day to the maximum daily dose of 2 x 100 mg cefpodoxime (in children with body weight above 25 kg). Note that: 5 ml of suspension contains the equivalent to 40 mg Cefpodoxime. 1 ml of suspension contains the equivalent to 8 mg Cefpodoxime. THE DOSING SYRINGE IS GRADUATED IN KG (FROM 5 TO 2 Read the complete document